Our study showed that reducing AZGP1 levels promoted the proliferation, migration, invasion, and EMT of ICC cells, possibly by activating the TGF-β1/Smad3 signaling pathway and promoting EMT in ICC cells. The gene discussed is AZGP1; the disease is intrahepatic cholangiocarcinoma.